LIN ($253.12) is undervalued by 3.74% relative to our estimate of its Fair Value price of $262.95 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
LIN ($253.12) is trading below its intrinsic value of $561.37, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
LIN is poor value based on its earnings relative to its share price (59.98x), compared to the US market average (31.52x)
Valuation
1 of 11
LIN News
Valuation
LIN fair value
Fair Value of LIN stock based on Discounted Cash Flow (DCF)
LIN ($253.12) is undervalued by 3.74% relative to our estimate of its Fair Value price of $262.95 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Valuation
LIN ($253.12) is trading below its intrinsic value of $561.37, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"
Valuation
LIN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
59.98x
Industry
36.18x
Market
31.52x
LIN is poor value based on its earnings relative to its share price (59.98x), compared to the US market average (31.52x)
Valuation
LIN is poor value based on its earnings relative to its share price (59.98x), compared to the US Specialty Chemicals industry average (36.18x)
Valuation
LIN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.88x
Industry
6.48x
Market
56.65x
LIN is good value based on its book value relative to its share price (2.88x), compared to the US market average (56.65x)
Valuation
LIN is good value based on its book value relative to its share price (2.88x), compared to the US Specialty Chemicals industry average (6.48x)
Valuation
LIN price to earnings growth (PEG)
For valuing profitable companies with growth potential
LIN is poor value relative to its rate of earnings growth, measured by PEG ratio (1.59x)
Valuation
LIN's financial health
Profit margin
Revenue
$6.9B
Net Income
$700.0M
Profit Margin
10.2%
LIN's Earnings (EBIT) of $3.09B can safely cover interest payments on company debt ($17.80B)
Financials
LIN's profit margin has decreased (-9.3%) in the last year from (17.6%) to (8.3%)
Financials
Assets to liabilities
Assets
$87.2B
Liabilities
$38.6B
Debt to equity
0.39
LIN's short-term liabilities ($14.79B) exceed its short-term assets ($12.27B)
Financials
LIN's long-term liabilities ($23.83B) exceed its short-term assets ($12.27B)
Financials
LIN's debt to equity ratio (0.84) is considered high
Financials
Cash flow
Operating
$1.9B
Investing
-$732.0M
Financing
-$933.0M
LIN's operating cash flow ($7.17B) is sufficient to service the company's debt ($17.80B)
Financials
Linde Stock FAQ
What is Linde's quote symbol?
(NYSE: LIN) Linde trades on the NYSE under the ticker symbol LIN. Linde stock quotes can also be displayed as NYSE: LIN.
How much is Linde's stock price per share?
(NYSE: LIN) Linde stock price per share is $253.12 today (as of Jan 25, 2021).
What is the 52 week high and low for Linde (NYSE: LIN)?
(NYSE: LIN) Linde's 52-week high was $274.58, and its 52-week low was $146.71. It is currently -7.81% from its 52-week high and 72.53% from its 52-week low.
What is Linde's Market Cap?
(NYSE: LIN) Linde's market cap is $132.98B, as of Jan 27, 2021.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Linde's market cap is calculated by multiplying LIN's current stock price of $253.12 by LIN's total outstanding shares of 525,360,032.
How much is Linde stock worth today?
(NYSE: LIN) Linde currently has 525,360,032 outstanding shares. With Linde stock trading at $253.12 per share, the total value of Linde stock (market capitalization) is $132.98B.
Linde stock was originally listed at a price of $165.47 in Oct 31, 2018. If you had invested in Linde stock at $165.47, your return over the last 2 years would have been 52.97%, for an annualized return of 23.68%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.